成人头颈部横纹肌肉瘤:管理、结局及调强放疗对局部区域控制的影响
该研究回顾了1984至2017年治疗的58例成人头颈部横纹肌肉瘤(HNRMS),中位年龄32岁,76%为脑膜旁肿瘤,45%肿瘤>5 cm。在45例M0期以治愈为目的治疗的患者中,33例为胚胎型/腺泡型(E/A),12例为多形型(P)。E/A-HNRMS接受新辅助化疗、根治性放化疗(CRT)及维持化疗,P-HNRMS一般接受手术±放疗;2005年起采用调强放疗(IMRT)。IMRT时代局部区域控制优于IMRT前时代(P = .049)。
要点
- 58例成人HNRMS中76%为脑膜旁肿瘤,45%肿瘤>5 cm,中位年龄32岁。
- M0期E/A-HNRMS在IMRT前时代局部区域复发12/23(52%),IMRT时代局部复发1/10(10%)。
- E/A-HNRMS远处转移为主要失败模式(17/33,52%),作者认为CRT应考虑用于该人群多数患者。
核心结论
- 作者结论认为,成人E/A-HNRMS采用IMRT行根治性CRT后局部区域控制率高,CRT应考虑用于该人群多数患者。
- 作者结论指出P-HNRMS为不同疾病,需要手术±放疗。
研究设计与样本
- 回顾性分析1984至2017年治疗的成人HNRMS,共58例符合条件,中位年龄32岁。
- HNRMS分为胚胎型/腺泡型(E/A)或多形型(P);E/A-HNRMS采用新辅助化疗、根治性放化疗(CRT)及维持化疗,P-HNRMS一般接受手术±放疗。
- 2005年起采用IMRT;E/A-HNRMS根治性放疗剂量为66至70 Gy,每次2 Gy,常规行选择性淋巴结放疗。
主要发现
- 58例中76%(n = 45)为脑膜旁肿瘤,45%(n = 26)肿瘤>5 cm。
- 45例M0期以治愈为目的治疗的患者中,33例(73%)为E/A-HNRMS,12例(27%)为P-HNRMS。
- IMRT前时代(2005年前)M0期E/A-HNRMS局部区域复发为12/23(52%);IMRT时代(2005年及以后)M0期患者局部复发为1/10(10%)。
- IMRT时代局部区域控制优于IMRT前时代(P = .049)。
- E/A-HNRMS患者远处转移为主要治疗失败模式(33例中17例,52%)。
关键数值与推荐
- E/A-HNRMS根治性放疗剂量为66至70 Gy,每次2 Gy,常规行选择性淋巴结放疗。
- IMRT前时代M0期E/A-HNRMS局部区域复发12/23(52%),IMRT时代局部复发1/10(10%),局部区域控制IMRT时代优于IMRT前时代(P = .049)。
临床怎么用
- 作者认为,CRT应考虑用于成人E/A-HNRMS人群的多数患者。
- 作者指出,P-HNRMS为不同疾病,需要手术±放疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Only 9% of adult rhabdomyosarcomas (RMS) present with primary disease in the head and neck (HNRMS). Management is often extrapolated from the pediatric experience in which prognosis is better but treatment imperatives differ. We report management and outcomes of adult HNRMS treated over 3 decades. METHODS AND MATERIALS: Adult HNRMS treated from 1984 to 2017 were reviewed. HNRMS were categorized as embryonal/alveolar (E/A) or pleomorphic (P). Standard management was as follows: E/A-HNRMS were treated with neoadjuvant chemotherapy, definitive chemoradiotherapy (CRT), and then maintenance chemotherapy. P-HNRMS were generally treated with surgery +/- radiation. Intensity modulated radiation therapy (IMRT) was adopted from 2005 onward. RESULTS: Fifty-eight patients were eligible; the median age was 32 years. Seventy-six percent of tumors (n = 45) were parameningeal and 45% (n = 26) were >5 cm. Of 45 patients with M0 HNRMS treated with curative intent, 33 (73%) were E/A-HNRMS and 12 (27%) P-HNRMS. Patients with E/A-HNRMS received definitive RT with 66 to 70 Gy in 2 Gy per fraction. Elective nodal RT was routinely delivered. In the pre-IMRT era (before 2005), 12 of 23 (52%) patients with M0 E/A-HNRMS experienced locoregional recurrences. In the IMRT era (2005 and onward), 1 of 10 patients (10%) with M0 disease recurred locally; this patient achieved a complete clinical response despite a 3-week interruption after 48 Gy because of local toxicity but experienced an in-field local recurrence 45 months later that resulted in death. Locoregional control was superior in the IMRT era vs pre-IMRT era (P = .049). Distant metastasis among patients with E/A-HNRMS was the predominant mode of treatment failure (n = 17 of 33, 52%). CONCLUSIONS: Our study shows a high rate of locoregional control for adult E/A-HNRMS following definitive CRT using IMRT, and CRT should be considered for the majority of patients in this population. In contrast, P-HNRMS is distinct and requires surgery +/- RT.
引用
- Hahn E, Barot S, O'Sullivan B, et al. Adult Head and Neck Rhabdomyosarcoma: Management, Outcomes, and the Effect of Intensity Modulated Radiation Therapy on Locoregional Control. Adv Radiat Oncol. 2022. PMID: 36420200. doi:10.1016/j.adro.2022.101055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。